Drug To Prevent Premature Birth Divides Doctors, Insurers And FDA Experts

An expert panel convened by the FDA says the drug Makena should be withdrawn from the market because a review of its effectiveness shows it doesn't work. But OB-GYNS who prescribe the drug disagree.

(Image credit: Luis Davilla/Getty Images)